Previous Article | Next Article 
Molecular and Cellular Biology, November 2000, p. 8420-8431, Vol. 20, No. 22
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
p53 Binds Selectively to the 5' Untranslated Region of
cdk4, an RNA Element Necessary and Sufficient for
Transforming Growth Factor
- and p53-Mediated Translational
Inhibition of cdk4
Susan J.
Miller,1,
Tuangporn
Suthiphongchai,1,
Gerard P.
Zambetti,2 and
Mark E.
Ewen1,*
Dana-Farber Cancer Institute and Harvard
Medical School, Boston, Massachusetts 02115,1
and Department of Biochemistry, St. Jude Children's
Research Hospital, Memphis, Tennessee 381052
Received 15 June 2000/Returned for modification 22 August
2000/Accepted 1 September 2000
One consequence of transforming growth factor
(TGF-
)
treatment is inhibition of Cdk4 synthesis, and this is dependent on p53. Here, we show that the 5' untranslated region (UTR) of the cdk4 mRNA is both necessary and sufficient
for wild-type p53-dependent TGF-
-regulated translational inhibition
of cdk4. Wild-type p53 bound selectively to the 5' UTR of
the cdk4 mRNA and inhibited translation of RNAs that
contain this region. RNA binding and translational control
are two genetically separable functions of p53, as are specific and
nonspecific RNA binding. Moreover, transactivation-defective mutants of
p53 retain the ability to regulate cdk4 translation. Our
findings suggest that p53 functions as a regulator of translation in
response to TGF-
in vivo.
*
Corresponding author. Mailing address: Dana-Farber
Cancer Institute and Harvard Medical School, 44 Binney St., Boston, MA 02115. Phone: (617) 632-2206. Fax: (617) 632-5417. E-mail:
mark_ewen{at}dfci.harvard.edu.

Present address: Cancer Biology Program, Division of
Hematology-Oncology, Department of Medicine, Beth Israel Deaconess
Medical
Center and Harvard Medical School, Boston, MA
02215.

Present address: Department of Biochemistry, Faculty of Science,
Mahidol University, Bangkok 10400,
Thailand.
Molecular and Cellular Biology, November 2000, p. 8420-8431, Vol. 20, No. 22
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Qin, Q., Baudry, M., Liao, G., Noniyev, A., Galeano, J., Bi, X.
(2009). A Novel Function for p53: Regulation of Growth Cone Motility through Interaction with Rho Kinase. J. Neurosci.
29: 5183-5192
[Abstract]
[Full Text]
-
Horvilleur, E., Bauer, M., Goldschneider, D., Mergui, X., de La Motte, A., Benard, J., Douc-Rasy, S., Cappellen, D.
(2008). p73{alpha} isoforms drive opposite transcriptional and post-transcriptional regulation of MYCN expression in neuroblastoma cells. Nucleic Acids Res
36: 4222-4232
[Abstract]
[Full Text]
-
Riley, K. J.-L., Maher, L. J. III
(2007). p53 RNA interactions: New clues in an old mystery. RNA
13: 1825-1833
[Abstract]
[Full Text]
-
Nie, M., Htun, H.
(2006). Different modes and potencies of translational repression by sequence-specific RNA-protein interaction at the 5'-UTR. Nucleic Acids Res
34: 5528-5540
[Abstract]
[Full Text]
-
RILEY, K. J.-L., CASSIDAY, L. A., KUMAR, A., MAHER, L. J. III
(2006). Recognition of RNA by the p53 tumor suppressor protein in the yeast three-hybrid system.. RNA
12: 620-630
[Abstract]
[Full Text]
-
Xi, Y., Shalgi, R., Fodstad, O., Pilpel, Y., Ju, J.
(2006). Differentially Regulated Micro-RNAs and Actively Translated Messenger RNA Transcripts by Tumor Suppressor p53 in Colon Cancer.. Clin. Cancer Res.
12: 2014-2024
[Abstract]
[Full Text]
-
Meng, Z., King, P. H., Nabors, L. B., Jackson, N. L., Chen, C.-Y., Emanuel, P. D., Blume, S. W.
(2005). The ELAV RNA-stability factor HuR binds the 5'-untranslated region of the human IGF-IR transcript and differentially represses cap-dependent and IRES-mediated translation. Nucleic Acids Res
33: 2962-2979
[Abstract]
[Full Text]
-
Fukuda, T., Ashizuka, M., Nakamura, T., Shibahara, K., Maeda, K., Izumi, H., Kohno, K., Kuwano, M., Uchiumi, T.
(2004). Characterization of the 5'-untranslated region of YB-1 mRNA and autoregulation of translation by YB-1 protein. Nucleic Acids Res
32: 611-622
[Abstract]
[Full Text]
-
Itoh, T., O'Shea, C., Linn, S.
(2003). Impaired Regulation of Tumor Suppressor p53 Caused by Mutations in the Xeroderma Pigmentosum DDB2 Gene: Mutual Regulatory Interactions between p48DDB2 and p53. Mol. Cell. Biol.
23: 7540-7553
[Abstract]
[Full Text]
-
Strudwick, S., Carastro, L. M., Stagg, T., Lazarus, P.
(2003). Differential Transcription-Coupled Translational Inhibition of Human p53 Expression: A Potentially Important Mechanism of Regulating p53 Expression in Normal versus Tumor Tissue. Mol Cancer Res
1: 463-474
[Abstract]
[Full Text]
-
Cassiday, L. A., Maher III, L. J.
(2002). Having it both ways: transcription factors that bind DNA and RNA. Nucleic Acids Res
30: 4118-4126
[Abstract]
[Full Text]
-
Borden, K. L. B.
(2002). Pondering the Promyelocytic Leukemia Protein (PML) Puzzle: Possible Functions for PML Nuclear Bodies. Mol. Cell. Biol.
22: 5259-5269
[Full Text]
-
Adilakshmi, T., Laine, R. O.
(2002). Ribosomal Protein S25 mRNA Partners with MTF-1 and La to Provide a p53-mediated Mechanism for Survival or Death. J. Biol. Chem.
277: 4147-4151
[Abstract]
[Full Text]